Sometimes, the most expensive mistakes hide in plain sight - or, more accurately, out of sight, behind a freezer door. Ask a study team why biospecimens fail, and you’ll hear about a collection technique or a courier who missed a pickup. Fair. But the quiet failure mode is storage. It’s distributed, assumed, and rarely engineered with the same rigor we give randomization or endpoint analysis. Six months later, storage comes back as assay variability, re‑runs, CAPAs, and a tim

Biospecimen logistics in clinical trials are often an afterthought—until something goes wrong. From customs delays to misrouted samples, this post explores the hidden chaos of sample shipping and how to build a resilient, operations-first strategy that ensures sample integrity, even under pressure.

When biospecimen processing fails, it’s not usually the science—it’s the gap between protocol and practice. From centrifuge errors to customs delays, silent pre-analytical variables sabotage the biospecimen lifecycle long before the assay begins. If we don’t build operational readiness into our protocols, even the most promising biomarker study can unravel before the data is even analyzed.